- Report
- February 2023
- 190 Pages
Global
From €5298EUR$5,899USD£4,526GBP
- Report
- August 2022
- 121 Pages
Global
From €1167EUR$1,299USD£997GBP
- Report
- August 2025
- 196 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3144EUR$3,500USD£2,685GBP
- Report
- July 2024
- 182 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- July 2023
- 145 Pages
Global
From €2829EUR$3,150USD£2,417GBP
Molecular Medicine is a branch of pharmaceuticals that focuses on the study of molecular mechanisms of disease and the development of treatments based on this knowledge. It is a rapidly growing field, with advances in biotechnology and genomics leading to the development of new treatments and diagnostics. Molecular Medicine is closely linked to personalized medicine, which uses genetic information to tailor treatments to individual patients. This approach has the potential to improve patient outcomes and reduce healthcare costs.
Molecular Medicine is a key component of the pharmaceutical industry, with many companies investing in research and development of new treatments. Examples of companies in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
